Michael Kalb
Directeur Financier/CFO chez CATALYST PHARMACEUTICALS, INC.
Postes actifs de Michael Kalb
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/01/2024 | - |
Historique de carrière de Michael Kalb
Anciens postes connus de Michael Kalb
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IPI LEGACY LIQUIDATION CO | Directeur Financier/CFO | 10/05/2023 | 31/12/2023 |
| CINCOR PHARMA, INC. | Comptroller/Controller/Auditor | 04/11/2022 | 01/03/2023 |
| Directeur Financier/CFO | 04/11/2022 | 01/03/2023 | |
| AMARIN CORPORATION PLC | Directeur Financier/CFO | 30/06/2016 | 20/06/2022 |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Comptroller/Controller/Auditor | 15/11/2010 | 29/06/2016 |
| Directeur Financier/CFO | 22/11/2010 | 29/06/2016 | |
| HURON CONSULTING GROUP INC. | Comptroller/Controller/Auditor | - | - |
Taro Pharmaceuticals U.S.A., Inc.
 Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Part of Sun Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. is a company that manufactures and sells generic pharmaceutical products. The company is based in Hawthorne, NY. | Directeur Financier/CFO | 01/06/2009 | - |
Formation de Michael Kalb
| State University of New York at Albany | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Israël | 2 |
| Irlande | 2 |
Opérationnelle
| Director of Finance/CFO | 6 |
| Comptroller/Controller/Auditor | 3 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
| AMARIN CORPORATION PLC | Health Technology |
| HURON CONSULTING GROUP INC. | Commercial Services |
| IPI LEGACY LIQUIDATION CO | Health Technology |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Taro Pharmaceuticals U.S.A., Inc.
Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Part of Sun Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. is a company that manufactures and sells generic pharmaceutical products. The company is based in Hawthorne, NY. | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Michael Kalb
- Expérience
